简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
ILUVATAR COREX
ILUVATAR COREX(09903.HK) closed 20.22% higher, the Hang Seng Semiconductors Sector posted broad gains
Tags：
ILUVATAR COREX
09903.HK
NewTimeSpace
2026-05-04
ILUVATAR COREX(09903.HK) closed 9.37% lower, closing at HKD 414.2
Tags：
ILUVATAR COREX
09903.HK
closing price
2026-04-27
ILUVATAR COREX(09903.HK) closed 9.54% higher
Tags：
ILUVATAR COREX
09903.HK
2026-04-24
NewTimeSpace | Breaking Through with High R&D Amidst Nearly 3 Billion RMB in Losses! Iluvatar CoreX (09903.HK) Share Price Hits New High, Market Cap Surpasses 80 Billion
Tags：
ILUVATAR COREX
09903.HK
NewTimeSpace
2026-03-11
ILUVATAR COREX(09903.HK) closed 8.44% higher, the Hang Seng Semiconductors Sector saw divergent trends
Tags：
ILUVATAR COREX
09903.HK
2026-01-08
Featured News
Finance
China Longyuan Power (00916.HK): Implementation of 2025 Equity Distribution, Final Dividend of RMB 0.625 per 10 Shares
Finance
Shenwan Hongyuan (06806.HK): Subsidiary’s RMB 3.6 Billion Corporate Bonds Listed on Shenzhen Stock Exchange
Finance
New Focus (00360.HK): Appointment of Hord Capital as Independent Financial Adviser
Finance
China Everbright Greentech (01257.HK): Entered Framework Agreements for Hazardous Waste Disposal Services Covering 2026 to 2028
Finance
Muyuan Co., Ltd. (02714.HK): Completes Corporate Name Change
Finance
CGII HLDGS (01940.HK): Completion of Loan Assignment
Finance
Guofu Hydrogen Energy (02582.HK): H-share Full Circulation Granted Listing Approval by HKEX
Finance
Wise Wealth Resources Investment (00007.HK): Appointment of Hao Xiaohui as Executive Director and Co-Chairman, Xu Shiping Re-designated as Co-Chairman
Finance
Fosun Pharma (02196.HK): Controlled Subsidiary’s HLX3902 Injection Obtains Clinical Trial Approval
Finance
Xunhe Group (01591.HK): Expected Annual Loss to Widen to HK$13 Million – HK$16 Million
Scan QR Code
Download App
